Pancreatic Islet Regeneration. The Developmental and Stem Cell Biology Approach.

Giacomo Lanzoni, Camillo Ricordi, Luca A Inverardi, Juan Dominguez-Bendala

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The quest for therapies that can normalize blood glucose control and provide independence from exogenous insulin could impact the life of millions of patients with type 1 diabetes (T1D) and a significant subset of patients with type 2 diabetes (T2D) with a functional deficiency in insulin production. Islet transplantation could be considered the first clinically successful cell therapy for T1D, but its widespread application is still hampered by the need for immunosuppression and the scarcity of organs available for processing and transplantation. The existence of these roadblocks has fostered the development of alternative approaches aimed at identifying high-yield sources of insulin-producing cells. Here we will discuss the state of the art in regenerative therapies for pancreatic islets, from stem cells to reprogramming. An outlook of the pancreatic development blueprint will help us in understanding key steps of stem cell differentiation, guiding us in the design of clinically translatable strategies. Major hurdles remain to be overcome for these approaches to find their way to the clinic: of these, we will specifically emphasize yield, safety, and immunological challenges.

Original languageEnglish
Title of host publicationRegenerative Medicine Applications in Organ Transplantation
PublisherElsevier Inc.
Pages609-625
Number of pages17
ISBN (Print)9780123985231
DOIs
StatePublished - Jun 27 2014

Fingerprint

Cytology
Medical problems
Stem cells
Islets of Langerhans
Cell Biology
Regeneration
Stem Cells
Insulin
Type 1 Diabetes Mellitus
Blueprints
Islets of Langerhans Transplantation
Cell- and Tissue-Based Therapy
Immunosuppression
Type 2 Diabetes Mellitus
Blood Glucose
Cell Differentiation
Transplantation
Safety
Therapeutics
Processing

Keywords

  • β-cell differentiation
  • Diabetes
  • Insulin
  • Islet development
  • Pancreas
  • Pancreatic β cell
  • Reprogramming
  • Stem cells

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Lanzoni, G., Ricordi, C., Inverardi, L. A., & Dominguez-Bendala, J. (2014). Pancreatic Islet Regeneration. The Developmental and Stem Cell Biology Approach. In Regenerative Medicine Applications in Organ Transplantation (pp. 609-625). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-398523-1.00042-2

Pancreatic Islet Regeneration. The Developmental and Stem Cell Biology Approach. / Lanzoni, Giacomo; Ricordi, Camillo; Inverardi, Luca A; Dominguez-Bendala, Juan.

Regenerative Medicine Applications in Organ Transplantation. Elsevier Inc., 2014. p. 609-625.

Research output: Chapter in Book/Report/Conference proceedingChapter

Lanzoni, G, Ricordi, C, Inverardi, LA & Dominguez-Bendala, J 2014, Pancreatic Islet Regeneration. The Developmental and Stem Cell Biology Approach. in Regenerative Medicine Applications in Organ Transplantation. Elsevier Inc., pp. 609-625. https://doi.org/10.1016/B978-0-12-398523-1.00042-2
Lanzoni G, Ricordi C, Inverardi LA, Dominguez-Bendala J. Pancreatic Islet Regeneration. The Developmental and Stem Cell Biology Approach. In Regenerative Medicine Applications in Organ Transplantation. Elsevier Inc. 2014. p. 609-625 https://doi.org/10.1016/B978-0-12-398523-1.00042-2
Lanzoni, Giacomo ; Ricordi, Camillo ; Inverardi, Luca A ; Dominguez-Bendala, Juan. / Pancreatic Islet Regeneration. The Developmental and Stem Cell Biology Approach. Regenerative Medicine Applications in Organ Transplantation. Elsevier Inc., 2014. pp. 609-625
@inbook{02fcd1dc7c5b4eb69579a67046076c72,
title = "Pancreatic Islet Regeneration. The Developmental and Stem Cell Biology Approach.",
abstract = "The quest for therapies that can normalize blood glucose control and provide independence from exogenous insulin could impact the life of millions of patients with type 1 diabetes (T1D) and a significant subset of patients with type 2 diabetes (T2D) with a functional deficiency in insulin production. Islet transplantation could be considered the first clinically successful cell therapy for T1D, but its widespread application is still hampered by the need for immunosuppression and the scarcity of organs available for processing and transplantation. The existence of these roadblocks has fostered the development of alternative approaches aimed at identifying high-yield sources of insulin-producing cells. Here we will discuss the state of the art in regenerative therapies for pancreatic islets, from stem cells to reprogramming. An outlook of the pancreatic development blueprint will help us in understanding key steps of stem cell differentiation, guiding us in the design of clinically translatable strategies. Major hurdles remain to be overcome for these approaches to find their way to the clinic: of these, we will specifically emphasize yield, safety, and immunological challenges.",
keywords = "β-cell differentiation, Diabetes, Insulin, Islet development, Pancreas, Pancreatic β cell, Reprogramming, Stem cells",
author = "Giacomo Lanzoni and Camillo Ricordi and Inverardi, {Luca A} and Juan Dominguez-Bendala",
year = "2014",
month = "6",
day = "27",
doi = "10.1016/B978-0-12-398523-1.00042-2",
language = "English",
isbn = "9780123985231",
pages = "609--625",
booktitle = "Regenerative Medicine Applications in Organ Transplantation",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Pancreatic Islet Regeneration. The Developmental and Stem Cell Biology Approach.

AU - Lanzoni, Giacomo

AU - Ricordi, Camillo

AU - Inverardi, Luca A

AU - Dominguez-Bendala, Juan

PY - 2014/6/27

Y1 - 2014/6/27

N2 - The quest for therapies that can normalize blood glucose control and provide independence from exogenous insulin could impact the life of millions of patients with type 1 diabetes (T1D) and a significant subset of patients with type 2 diabetes (T2D) with a functional deficiency in insulin production. Islet transplantation could be considered the first clinically successful cell therapy for T1D, but its widespread application is still hampered by the need for immunosuppression and the scarcity of organs available for processing and transplantation. The existence of these roadblocks has fostered the development of alternative approaches aimed at identifying high-yield sources of insulin-producing cells. Here we will discuss the state of the art in regenerative therapies for pancreatic islets, from stem cells to reprogramming. An outlook of the pancreatic development blueprint will help us in understanding key steps of stem cell differentiation, guiding us in the design of clinically translatable strategies. Major hurdles remain to be overcome for these approaches to find their way to the clinic: of these, we will specifically emphasize yield, safety, and immunological challenges.

AB - The quest for therapies that can normalize blood glucose control and provide independence from exogenous insulin could impact the life of millions of patients with type 1 diabetes (T1D) and a significant subset of patients with type 2 diabetes (T2D) with a functional deficiency in insulin production. Islet transplantation could be considered the first clinically successful cell therapy for T1D, but its widespread application is still hampered by the need for immunosuppression and the scarcity of organs available for processing and transplantation. The existence of these roadblocks has fostered the development of alternative approaches aimed at identifying high-yield sources of insulin-producing cells. Here we will discuss the state of the art in regenerative therapies for pancreatic islets, from stem cells to reprogramming. An outlook of the pancreatic development blueprint will help us in understanding key steps of stem cell differentiation, guiding us in the design of clinically translatable strategies. Major hurdles remain to be overcome for these approaches to find their way to the clinic: of these, we will specifically emphasize yield, safety, and immunological challenges.

KW - β-cell differentiation

KW - Diabetes

KW - Insulin

KW - Islet development

KW - Pancreas

KW - Pancreatic β cell

KW - Reprogramming

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=84902914793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902914793&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-398523-1.00042-2

DO - 10.1016/B978-0-12-398523-1.00042-2

M3 - Chapter

AN - SCOPUS:84902914793

SN - 9780123985231

SP - 609

EP - 625

BT - Regenerative Medicine Applications in Organ Transplantation

PB - Elsevier Inc.

ER -